1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Beta-lactams Drugs 1.2.3 Carbapenems Drugs 1.2.4 Fluoroquinolones Drugs 1.2.5 Others 1.3 Market by Application 1.3.1 Global Enterobacteriaceae Infection Drug Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Enterobacteriaceae Infection Drug Market Perspective (2016-2027) 2.2 Enterobacteriaceae Infection Drug Growth Trends by Regions 2.2.1 Enterobacteriaceae Infection Drug Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Enterobacteriaceae Infection Drug Historic Market Share by Regions (2016-2021) 2.2.3 Enterobacteriaceae Infection Drug Forecasted Market Size by Regions (2022-2027) 2.3 Enterobacteriaceae Infection Drug Industry Dynamic 2.3.1 Enterobacteriaceae Infection Drug Market Trends 2.3.2 Enterobacteriaceae Infection Drug Market Drivers 2.3.3 Enterobacteriaceae Infection Drug Market Challenges 2.3.4 Enterobacteriaceae Infection Drug Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue 3.1.1 Global Top Enterobacteriaceae Infection Drug Players by Revenue (2016-2021) 3.1.2 Global Enterobacteriaceae Infection Drug Revenue Market Share by Players (2016-2021) 3.2 Global Enterobacteriaceae Infection Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Enterobacteriaceae Infection Drug Revenue 3.4 Global Enterobacteriaceae Infection Drug Market Concentration Ratio 3.4.1 Global Enterobacteriaceae Infection Drug Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Enterobacteriaceae Infection Drug Revenue in 2020 3.5 Enterobacteriaceae Infection Drug Key Players Head office and Area Served 3.6 Key Players Enterobacteriaceae Infection Drug Product Solution and Service 3.7 Date of Enter into Enterobacteriaceae Infection Drug Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Enterobacteriaceae Infection Drug Breakdown Data by Type 4.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Type (2016-2021) 4.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2022-2027) 5 Enterobacteriaceae Infection Drug Breakdown Data by Application 5.1 Global Enterobacteriaceae Infection Drug Historic Market Size by Application (2016-2021) 5.2 Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Enterobacteriaceae Infection Drug Market Size (2016-2027) 6.2 North America Enterobacteriaceae Infection Drug Market Size by Type 6.2.1 North America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) 6.2.2 North America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) 6.2.3 North America Enterobacteriaceae Infection Drug Market Size by Type (2016-2027) 6.3 North America Enterobacteriaceae Infection Drug Market Size by Application 6.3.1 North America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) 6.3.2 North America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) 6.3.3 North America Enterobacteriaceae Infection Drug Market Size by Application (2016-2027) 6.4 North America Enterobacteriaceae Infection Drug Market Size by Country 6.4.1 North America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) 6.4.2 North America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Enterobacteriaceae Infection Drug Market Size (2016-2027) 7.2 Europe Enterobacteriaceae Infection Drug Market Size by Type 7.2.1 Europe Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) 7.2.2 Europe Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) 7.2.3 Europe Enterobacteriaceae Infection Drug Market Size by Type (2016-2027) 7.3 Europe Enterobacteriaceae Infection Drug Market Size by Application 7.3.1 Europe Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) 7.3.2 Europe Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) 7.3.3 Europe Enterobacteriaceae Infection Drug Market Size by Application (2016-2027) 7.4 Europe Enterobacteriaceae Infection Drug Market Size by Country 7.4.1 Europe Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) 7.4.2 Europe Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size (2016-2027) 8.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type 8.2.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2016-2027) 8.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application 8.3.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2016-2027) 8.4 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region 8.4.1 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Enterobacteriaceae Infection Drug Market Size (2016-2027) 9.2 Latin America Enterobacteriaceae Infection Drug Market Size by Type 9.2.1 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) 9.2.2 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) 9.2.3 Latin America Enterobacteriaceae Infection Drug Market Size by Type (2016-2027) 9.3 Latin America Enterobacteriaceae Infection Drug Market Size by Application 9.3.1 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) 9.3.2 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) 9.3.3 Latin America Enterobacteriaceae Infection Drug Market Size by Application (2016-2027) 9.4 Latin America Enterobacteriaceae Infection Drug Market Size by Country 9.4.1 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) 9.4.2 Latin America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size (2016-2027) 10.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type 10.2.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2016-2027) 10.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application 10.3.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2016-2027) 10.4 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country 10.4.1 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Genentech 11.1.1 Genentech Company Details 11.1.2 Genentech Business Overview 11.1.3 Genentech Enterobacteriaceae Infection Drug Introduction 11.1.4 Genentech Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.1.5 Genentech Recent Development 11.2 Nanotherapeutics 11.2.1 Nanotherapeutics Company Details 11.2.2 Nanotherapeutics Business Overview 11.2.3 Nanotherapeutics Enterobacteriaceae Infection Drug Introduction 11.2.4 Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.2.5 Nanotherapeutics Recent Development 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Enterobacteriaceae Infection Drug Introduction 11.3.4 Novartis Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.3.5 Novartis Recent Development 11.4 Pfizer 11.4.1 Pfizer Company Details 11.4.2 Pfizer Business Overview 11.4.3 Pfizer Enterobacteriaceae Infection Drug Introduction 11.4.4 Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.4.5 Pfizer Recent Development 11.5 Nymox Pharmaceutical 11.5.1 Nymox Pharmaceutical Company Details 11.5.2 Nymox Pharmaceutical Business Overview 11.5.3 Nymox Pharmaceutical Enterobacteriaceae Infection Drug Introduction 11.5.4 Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.5.5 Nymox Pharmaceutical Recent Development 11.6 Sequoia Sciences 11.6.1 Sequoia Sciences Company Details 11.6.2 Sequoia Sciences Business Overview 11.6.3 Sequoia Sciences Enterobacteriaceae Infection Drug Introduction 11.6.4 Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.6.5 Sequoia Sciences Recent Development 11.7 Phico Therapeutics 11.7.1 Phico Therapeutics Company Details 11.7.2 Phico Therapeutics Business Overview 11.7.3 Phico Therapeutics Enterobacteriaceae Infection Drug Introduction 11.7.4 Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.7.5 Phico Therapeutics Recent Development 11.8 Cantab Biopharmaceuticals 11.8.1 Cantab Biopharmaceuticals Company Details 11.8.2 Cantab Biopharmaceuticals Business Overview 11.8.3 Cantab Biopharmaceuticals Enterobacteriaceae Infection Drug Introduction 11.8.4 Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) 11.8.5 Cantab Biopharmaceuticals Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Enterobacteriaceae Infection Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Beta-lactams Drugs Table 3. Key Players of Carbapenems Drugs Table 4. Key Players of Fluoroquinolones Drugs Table 5. Key Players of Others Table 6. Global Enterobacteriaceae Infection Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Enterobacteriaceae Infection Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Enterobacteriaceae Infection Drug Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Enterobacteriaceae Infection Drug Market Share by Regions (2016-2021) Table 10. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Enterobacteriaceae Infection Drug Market Share by Regions (2022-2027) Table 12. Enterobacteriaceae Infection Drug Market Trends Table 13. Enterobacteriaceae Infection Drug Market Drivers Table 14. Enterobacteriaceae Infection Drug Market Challenges Table 15. Enterobacteriaceae Infection Drug Market Restraints Table 16. Global Enterobacteriaceae Infection Drug Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Enterobacteriaceae Infection Drug Market Share by Players (2016-2021) Table 18. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enterobacteriaceae Infection Drug as of 2020) Table 19. Ranking of Global Top Enterobacteriaceae Infection Drug Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Enterobacteriaceae Infection Drug Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Enterobacteriaceae Infection Drug Product Solution and Service Table 23. Date of Enter into Enterobacteriaceae Infection Drug Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million) Table 26. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2016-2021) Table 27. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Enterobacteriaceae Infection Drug Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2016-2021) Table 31. Global Enterobacteriaceae Infection Drug Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Enterobacteriaceae Infection Drug Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million) Table 34. North America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million) Table 36. North America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Enterobacteriaceae Infection Drug Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Enterobacteriaceae Infection Drug Market Size by Country (2022-2027) & (US$ Million) Table 63. Genentech Company Details Table 64. Genentech Business Overview Table 65. Genentech Enterobacteriaceae Infection Drug Product Table 66. Genentech Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 67. Genentech Recent Development Table 68. Nanotherapeutics Company Details Table 69. Nanotherapeutics Business Overview Table 70. Nanotherapeutics Enterobacteriaceae Infection Drug Product Table 71. Nanotherapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 72. Nanotherapeutics Recent Development Table 73. Novartis Company Details Table 74. Novartis Business Overview Table 75. Novartis Enterobacteriaceae Infection Drug Product Table 76. Novartis Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 77. Novartis Recent Development Table 78. Pfizer Company Details Table 79. Pfizer Business Overview Table 80. Pfizer Enterobacteriaceae Infection Drug Product Table 81. Pfizer Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 82. Pfizer Recent Development Table 83. Nymox Pharmaceutical Company Details Table 84. Nymox Pharmaceutical Business Overview Table 85. Nymox Pharmaceutical Enterobacteriaceae Infection Drug Product Table 86. Nymox Pharmaceutical Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 87. Nymox Pharmaceutical Recent Development Table 88. Sequoia Sciences Company Details Table 89. Sequoia Sciences Business Overview Table 90. Sequoia Sciences Enterobacteriaceae Infection Drug Product Table 91. Sequoia Sciences Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 92. Sequoia Sciences Recent Development Table 93. Phico Therapeutics Company Details Table 94. Phico Therapeutics Business Overview Table 95. Phico Therapeutics Enterobacteriaceae Infection Drug Product Table 96. Phico Therapeutics Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 97. Phico Therapeutics Recent Development Table 98. Cantab Biopharmaceuticals Company Details Table 99. Cantab Biopharmaceuticals Business Overview Table 100. Cantab Biopharmaceuticals Revenue in Enterobacteriaceae Infection Drug Business (2016-2021) & (US$ Million) Table 101. Cantab Biopharmaceuticals Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Enterobacteriaceae Infection Drug Market Share by Type: 2020 VS 2027 Figure 2. Beta-lactams Drugs Features Figure 3. Carbapenems Drugs Features Figure 4. Fluoroquinolones Drugs Features Figure 5. Others Features Figure 6. Global Enterobacteriaceae Infection Drug Market Share by Application: 2020 VS 2027 Figure 7. Hospital Pharmacies Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Enterobacteriaceae Infection Drug Report Years Considered Figure 11. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Enterobacteriaceae Infection Drug Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Enterobacteriaceae Infection Drug Market Share by Regions: 2020 VS 2027 Figure 14. Global Enterobacteriaceae Infection Drug Market Share by Regions (2022-2027) Figure 15. Global Enterobacteriaceae Infection Drug Market Share by Players in 2020 Figure 16. Global Top Enterobacteriaceae Infection Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Enterobacteriaceae Infection Drug as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Enterobacteriaceae Infection Drug Revenue in 2020 Figure 18. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2016-2021) Figure 19. Global Enterobacteriaceae Infection Drug Revenue Market Share by Type (2022-2027) Figure 20. North America Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Enterobacteriaceae Infection Drug Market Share by Type (2016-2027) Figure 22. North America Enterobacteriaceae Infection Drug Market Share by Application (2016-2027) Figure 23. North America Enterobacteriaceae Infection Drug Market Share by Country (2016-2027) Figure 24. United States Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Enterobacteriaceae Infection Drug Market Share by Type (2016-2027) Figure 28. Europe Enterobacteriaceae Infection Drug Market Share by Application (2016-2027) Figure 29. Europe Enterobacteriaceae Infection Drug Market Share by Country (2016-2027) Figure 30. Germany Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Type (2016-2027) Figure 38. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Application (2016-2027) Figure 39. Asia-Pacific Enterobacteriaceae Infection Drug Market Share by Region (2016-2027) Figure 40. China Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Enterobacteriaceae Infection Drug Market Share by Type (2016-2027) Figure 48. Latin America Enterobacteriaceae Infection Drug Market Share by Application (2016-2027) Figure 49. Latin America Enterobacteriaceae Infection Drug Market Share by Country (2016-2027) Figure 50. Mexico Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Type (2016-2027) Figure 54. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Application (2016-2027) Figure 55. Middle East & Africa Enterobacteriaceae Infection Drug Market Share by Country (2016-2027) Figure 56. Turkey Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Enterobacteriaceae Infection Drug Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Genentech Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 60. Nanotherapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 61. Novartis Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 62. Pfizer Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 63. Nymox Pharmaceutical Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 64. Sequoia Sciences Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 65. Phico Therapeutics Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 66. Cantab Biopharmaceuticals Revenue Growth Rate in Enterobacteriaceae Infection Drug Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Genentech Nanotherapeutics Novartis Pfizer Nymox Pharmaceutical Sequoia Sciences Phico Therapeutics Cantab Biopharmaceuticals